AXA S.A. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
AXA S.A. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$9,370,000
+93.2%
170,863
-19.5%
0.03%
+61.1%
Q3 2020$4,851,000
-46.0%
212,186
-50.5%
0.02%0.0%
Q2 2020$8,976,000
+58.1%
428,848
+5.4%
0.02%
+28.6%
Q1 2020$5,676,000
-43.0%
406,862
-6.9%
0.01%
-30.0%
Q4 2019$9,952,000
+99.6%
437,238
+2.2%
0.02%
+100.0%
Q3 2019$4,986,000
-22.5%
427,966
-0.2%
0.01%
-23.1%
Q2 2019$6,430,000
+74.8%
428,724
+104.5%
0.01%
-7.1%
Q1 2019$3,678,000
+53.4%
209,684
+29.6%
0.01%
+40.0%
Q4 2018$2,398,000
-24.3%
161,828
+25.8%
0.01%
-16.7%
Q3 2018$3,166,000128,6220.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders